J Wu,
Z Sun, S Yang,
J Fu, Y Fan, N Wang, J Hu, L Ma… - Molecular Therapy, 2022 - cell.com
Angiotensin receptor blockers (ARBs) and sodium-glucose cotransporter 2 inhibitors
(SGLT2i) have been used as the standard therapy for patients with diabetic kidney disease …